                         SEQUENCE LISTING

<110>  Therabs Corporation
 
<120>  CYTOPLASMIC AND NUCLEAR ANTIBODY COMPOSITIONS

<130>  459-2-PCT

<140>  PCT/US16/31425
<141>  2016-05-09

<150>  US 62/158,182
<151>  2015-05-07

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer sequence

<400>  1
aggtsmarct gcagsagtcw gg                                                22


<210>  2
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer sequence

<400>  2
cagggggctc tcgcaggaga cgagg                                             25


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer sequence

<400>  3
ggacagggat ccagagttcc                                                   20


